Form 4: Septerna Inc. Director Abraham Bassan Acquires Stock Options

Septerna, Inc. Director Abraham Bassan acquired 15,000 stock options with an exercise price of $37.34, vesting under specific service conditions.

Summary

• Abraham Bassan, a Director at Septerna, Inc., acquired 15,000 stock options on June 26, 2026.
• The stock options have an exercise price of $37.34 per share.
• These options are subject to vesting conditions, including continued service to the Issuer.
• The shares underlying the options will vest in full on the earlier of June 26, 2027, or the Issuer's next annual meeting of stockholders.
• A substitute Power of Attorney was filed on February 10, 2026, appointing Gil M. Labrucherie and Mark A. Wilson as substitute attorneys-in-fact for various individuals, including Abraham Bassan, for SEC filings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard grant of stock options to a director, which is a common form of compensation and incentive, rather than a significant event indicating strong positive or negative performance.

Positives

• Director Abraham Bassan's acquisition of stock options indicates a potential alignment of management interests with shareholder value, assuming the options are exercised and the stock price increases.
• The acquisition of options suggests a belief in the future growth and performance of Septerna, Inc.

Negatives

• The filing only details the acquisition of options, not the actual purchase of shares, so the immediate financial impact is not yet realized.
• The vesting schedule for the options means that the full benefit is contingent on continued service, which introduces an element of uncertainty.

Risks

• The value of the acquired stock options is directly tied to the future stock price of Septerna, Inc., which is subject to market volatility and company performance.
• The vesting of the options is contingent on the Reporting Person's continued service, creating a risk of forfeiture if service is terminated before the vesting date.

Future Outlook

The stock options acquired by Abraham Bassan are exercisable and vest under specific conditions related to continued service, with full vesting occurring by June 26, 2027, or the next annual meeting. The options expire on June 25, 2036.

Industry Context

StockSavvy.ai notes that the filing of a Form 4 by a director of Septerna, Inc. is a routine disclosure of changes in beneficial ownership, specifically the acquisition of stock options. This is common practice in the biotechnology and pharmaceutical sectors, where equity-based compensation is used to incentivize and retain key personnel.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition of stock options by a director may be viewed positively as it aligns management's interests with increasing shareholder value, provided the company performs well.
• Employees: The vesting schedule for the options is tied to continued service, which may incentivize directors to remain with the company.

Next Steps

• Abraham Bassan will continue to provide service to Septerna, Inc. through the vesting date.
• The stock options will vest in full on the earlier of June 26, 2027, or the Issuer's next annual meeting of stockholders.
• The stock options will expire on June 25, 2036.

Key Dates

Keywords

Form 4, SEC Filing, Stock Options, Beneficial Ownership, Septerna Inc., Abraham Bassan, Director, Insider Trading, Vesting Schedule, Power of Attorney